Patients With Therapy-Related CMML Have Shorter Median Overall Survival Than Those With De Novo CMML: Mayo Clinic Long-Term Follow-Up Experience

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

Sonali M. Smith, Michelle M. Le Beau, Dezheng Huo et al. · Blood · 2003 · 675 citations

Medicine, Hematology, Oncology +17

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

Sabine Käyser, Konstanze Döhner, Jürgen Krauter et al. · Blood · 2010 · 485 citations

Medicine, Hematology, Oncology +11

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

Hagop M. Kantarjian, Susan O’Brien, Farhad Ravandi et al. · Cancer · 2008 · 485 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

Esperanza Such, Ulrich Germing, Luca Malcovati et al. · Blood · 2013 · 317 citations · Full text

Medicine, Hematology, Oncology +13

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

Claudia Schoch, Wolfgang Kern, Susanne Schnittger et al. · Leukemia · 2003 · 285 citations

Life Sciences, Hematology, Oncology +13